The pathological diagnosis is slow-growing lymphoma, such as: marginal-zone B-cell lymphoma, Waldenstrom macroglobulinemia lymphocytic lymphoma, CLL/SLL, mantle cell lymphoma.
Have undergone or planned to undergo FDG PET scan for indications including initial staging, therapeutic response evaluation, or follow-up examinations within 3 to 6 months in the clinical observation group.
Able to lie flat for at least 30 minutes.
Signing the subject consent form.
ECOG grade 0-2.
The timing of F-18-FDG usage in this trial follows the "Lymphoma Treatment Principles" of our institution.
You may not be if
Pregnant woman
Severe renal impairment (eGRF\< 30ml/min)
Known or suspected allergy to radiopharmaceuticals
Concurrent or previous diagnosis of malignancies other than lymphoma
Inability to undergo the necessary PET scan procedure
Refusal or unwillingness to sign the informed consent form
Severe medical conditions (severe disabilities, mental disorders)